Literature DB >> 8017089

Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo.

G W Sandker1, R M Vos, L P Delbressine, M J Slooff, D K Meijer, G M Groothuis.   

Abstract

1. The metabolism of the three drugs (Org GB 94, Org 3770 and Org OD 14) was studied in isolated human and rat hepatocytes. The metabolic profiles in rat and human hepatocytes were compared with the available in vivo data in both species. 2. All three drugs were metabolized extensively under the conditions used, both in human and rat hepatocytes, showing both extensive phase I and II metabolism. 3. During 3-h incubation with rat hepatocytes the three compounds were metabolized completely, whereas incubation with human hepatocytes only resulted in partial metabolism, amounting for 58% (Org GB 94), 36% (Org 3770) and 94% (Org OD 14) of the dose. In addition, rat hepatocytes excreted relatively more of the formed metabolites than human hepatocytes. 4. For both species, the metabolites formed in the isolated cells were quite similar to those found in vivo. With respect to Org GB 94 and Org 3770, metabolites were detected in man in vivo and in isolated human hepatocytes that were not found in any of the animal species studied previously. 5. The reflection of interspecies differences in isolated hepatocytes, with respect to both metabolite profiles and human-specific metabolites, renders isolated human hepatocytes a very valuable tool during preclinical drug development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017089     DOI: 10.3109/00498259409043228

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

Review 1.  Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

2.  The in vivo metabolism of tibolone in animal species.

Authors:  C H J Verhoeven; R M E Vos; L P C Delbressine
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

3.  Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.

Authors:  Robin M Voigt; Amanda L Mickiewicz; T Celeste Napier
Journal:  Behav Brain Res       Date:  2011-07-12       Impact factor: 3.332

4.  Pharmacokinetics and biotransformation of mirtazapine in human volunteers.

Authors:  L P Delbressine; M E Moonen; F M Kaspersen; G N Wagenaars; P L Jacobs; C J Timmer; J E Paanakker; H J van Hal; G Voortman
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

5.  Hypertensive urgency after administration of a single low dose of mirtazapine-a case report.

Authors:  Jiana Shi; Xiaojun Wang; Yin Ying; Lin Xu; Danyan Zhu
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

6.  A Rapid and Sensitive HPLC-Fluorescence Method for Determination of Mirtazapine and Its two Major Metabolites in Human Plasma.

Authors:  Hoda Lavasani; Mario Giorgi; Behjat Sheikholeslami; Mohammadhasan Hedayati; Mohammad Reza Rouini
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 7.  A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.

Authors:  Ana S Serras; Joana S Rodrigues; Madalena Cipriano; Armanda V Rodrigues; Nuno G Oliveira; Joana P Miranda
Journal:  Front Cell Dev Biol       Date:  2021-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.